טוען...
Acute promyelocytic leukemia (APL): remaining challenges towards a cure for all
The application of all-trans retinoic acid (ATRA) and arsenic trioxide (ATO) has revolutionized the treatment of acute promyelocytic leukemia (APL). More than 80–90% of patients are expected to be cured with a combination of ATRA, ATO and/or chemotherapy. In this review, we focus on the remaining ob...
שמור ב:
| הוצא לאור ב: | Leuk Lymphoma |
|---|---|
| Main Authors: | , |
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
2019
|
| נושאים: | |
| גישה מקוונת: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7479633/ https://ncbi.nlm.nih.gov/pubmed/31842650 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/10428194.2019.1613540 |
| תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|